< Back to latest news & events

Knowledge Hub

Why the EPO’s top-up search for earlier national rights matters for the UP and UPC

January 2023

Before unitary effect can be registered by the EPO, an applicant must first obtain a European patent via the EPO as it does in the current way. In order to be eligible for registration as a Unitary Patent (“UP”), the European patent must have been granted with the same set of claims in respect of all the 25 participating Member States. This condition must be met irrespective of whether all these states will in fact be covered by the UP. This means that (i) withdrawing the designation of any of the 25 participating Member States rules out obtaining a UP and (ii) having a different set of claims for any of the participating Member States, would also prevent the EPO from registering a UP.

Earlier national rights (i.e. patent documents from the EPC contracting states that would potentially present a “novelty only” patentability problem) are not included in the state of the art for the purposes of the EPO’s examination for patentability (Article 54(3) EPC). This refers to national applications of which the filing dates are prior to the filing or priority date of the European application and which were published as national applications or patents on or after that date. However, under Article 139(2) EPC, after the European patent has been granted, earlier national rights can be invoked as a ground for revocation in national proceedings.

From 1 September 2022, the EPO has been carrying out systematic top-up searches to find such earlier national rights – this is usually reported as part of the EPO’s R71(3) communication (notice of intention to grant). The EPO already carries out a top-up search for European rights at the end of examination.

When it opens, the UPC may revoke a UP, either entirely or partly (Article 65 UPCA), only on the grounds referred to in Articles 138(1) and 139(2) of the EPC. As such, an earlier national right could become prior art against a UP before the UPC.

To avoid these earlier national rights, applicants can file separate sets of claims for countries in which earlier national rights are found (Rule 138 EPC). However, doing so would rule out a UP.

Applicants may therefore need to consider the finding of a national prior right carefully, as it will play into the decision on their validation strategy and whether a UP is the right approach.


This article was prepared by HGF Partners & Patent Attorneys Andy Camenisch and Dr Jennifer Uno

Latest updates

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details